December 11, 2018
New Mayo research focused on how women’s hormones affect aging
By Advancing the Science contributor
By Heather Carlson Kehren Mayo Clinic researchers are taking a closer look at differences in how women age and the role hormones may play in the process. To do that, they will focus on premenopausal women who have had both of their ovaries removed. Investigators will be looking to see how this abrupt loss of […]
Tags: Alzheimer's disease, Center for the Science of Health Care Delivery, Michelle Mielke, Rochester Epidemiology Project, women's health
August 24, 2017
UNTANGLING ALZHEIMER’S–Mayo Clinic’s approach
Families living with Alzheimer’s disease woke to devastating newspaper headlines recently: Another highly touted drug failed in clinical trials. Drugmaker Eli Lilly’s EXPEDITION3 trial tested an antibody, a molecule used by the immune system to fight off disease, called solanezumab. This experimental drug sought to remove harmful proteins in the brain that become building blocks for amyloid, […]
Tags: Alzheimer's disease, Michelle Mielke, Rochester Epidemiology Project